Press release
Crispy Innovation To Drive The Osteoporosis Drugs Market
The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2983
Company Profiles:
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Merck & Co, Inc.
Novartis AG
Amgen, Inc.
Novo Nordisk A/S
Actavis plc
Pfizer, Inc.
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd
Other
However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the growth of the market.
In North America, the prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases in the region.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2983
According to the U.S. Department of Health and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.
In Europe, increasing aging population, changing lifestyles, and increasing consumer awareness about osteoporosis care are driving the growth of the osteoporosis drug market.
According to International Osteoporosis Foundation, approximately 27.5 million people in Europe suffered from osteoporosis in 2010, and the number is expected to reach 33.9 Mn by 2030.
However, the growth of osteoporosis market in Asia Pacific is much due to rising geriatric population and changing lifestyles in the region. Osteoporotic patients have a higher risk of hip fractures, owing to a major cause of morbidity and mortality.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/2983
According to the International Osteoporosis Foundation, by 2050, approximately 1/2 of the world’s osteoporosis hip fractures would occur in women in Asia.
Related Reports:
Immune Checkpoint Inhibitors Market - https://www.persistencemarketresearch.com/market-research/immune-checkpoint-inhibitors-market.asp
Insomnia Treatment Market - https://www.persistencemarketresearch.com/market-research/insomnia-treatment-market.asp
Metagenomics Market - https://www.persistencemarketresearch.com/market-research/metagenomics-market.asp
Pharmaceutical Excipients Market - https://www.persistencemarketresearch.com/market-research/pharmaceutical-excipients-market.asp
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Crispy Innovation To Drive The Osteoporosis Drugs Market here
News-ID: 2420091 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Osteoporosis
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging populati …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot
Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of…
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022
The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%.
Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone…
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews
February 03, 2017
Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
